吉林医学
吉林醫學
길림의학
JILIN MEDICAL JOURANL
2013年
8期
1418-1419
,共2页
孟鲁司特%氨溴索%慢性阻塞性肺疾病%白三烯受体拮抗剂
孟魯司特%氨溴索%慢性阻塞性肺疾病%白三烯受體拮抗劑
맹로사특%안추색%만성조새성폐질병%백삼희수체길항제
Montelukast%Ambroxol%COPD%Leukotriene receptor antagonists
目的:探讨孟鲁司特片联合雾化吸入氨溴索治疗慢性阻塞性肺疾病的疗效.方法:选择慢性阻塞性肺疾病患者120例,随机分为治疗组和对照组,每组各60例.对照组:予抗感染等常规治疗.治疗组:予常规治疗同时加用口服孟鲁司特片10 mg,1次/晚;氨溴索注射液30 mg雾化吸入,2次/d,疗程2周.观察患者咳嗽、咯痰、喘息等主要临床症状明显缓解所需要时间及住院时间,并随访6个月观察复发情况.结果:治疗组患者咳嗽、咯痰、喘息等主要临床症状明显缓解所需要时间明显少于对照组,差异有统计学意义(P<0.01);治疗组住院时间少于对照组,并可减少复发次数,差异有统计学意义(P<0.05).结论:孟鲁司特片联合雾化吸入氨溴索可以更有效地治疗和控制慢性阻塞性肺疾病,值得临床进一步推广.
目的:探討孟魯司特片聯閤霧化吸入氨溴索治療慢性阻塞性肺疾病的療效.方法:選擇慢性阻塞性肺疾病患者120例,隨機分為治療組和對照組,每組各60例.對照組:予抗感染等常規治療.治療組:予常規治療同時加用口服孟魯司特片10 mg,1次/晚;氨溴索註射液30 mg霧化吸入,2次/d,療程2週.觀察患者咳嗽、咯痰、喘息等主要臨床癥狀明顯緩解所需要時間及住院時間,併隨訪6箇月觀察複髮情況.結果:治療組患者咳嗽、咯痰、喘息等主要臨床癥狀明顯緩解所需要時間明顯少于對照組,差異有統計學意義(P<0.01);治療組住院時間少于對照組,併可減少複髮次數,差異有統計學意義(P<0.05).結論:孟魯司特片聯閤霧化吸入氨溴索可以更有效地治療和控製慢性阻塞性肺疾病,值得臨床進一步推廣.
목적:탐토맹로사특편연합무화흡입안추색치료만성조새성폐질병적료효.방법:선택만성조새성폐질병환자120례,수궤분위치료조화대조조,매조각60례.대조조:여항감염등상규치료.치료조:여상규치료동시가용구복맹로사특편10 mg,1차/만;안추색주사액30 mg무화흡입,2차/d,료정2주.관찰환자해수、각담、천식등주요림상증상명현완해소수요시간급주원시간,병수방6개월관찰복발정황.결과:치료조환자해수、각담、천식등주요림상증상명현완해소수요시간명현소우대조조,차이유통계학의의(P<0.01);치료조주원시간소우대조조,병가감소복발차수,차이유통계학의의(P<0.05).결론:맹로사특편연합무화흡입안추색가이경유효지치료화공제만성조새성폐질병,치득림상진일보추엄.
Objective To explore the curative effect that montelukast joint atomization inhalation of ambroxol in the treatment of chronic obstructive pulmonary disease.Methods 120 patients were randomly divided into treatment group and control group,which have been diagnosed as chronic obstructive pulmonary disease in the respiratory medicine.Each group contained 60 patients.The method of treatment in control group was routine treatment.Excepting the routine treatment,treatment group also added that,oral montelukast piece(10 mg,qn),and atomization inhalation of ambroxol(30 mg,bid).The treatment course was 2 weeks.To observe days abou major clinical symptoms,such as cough,cough up phlegm,wheeze,which were obviously remitted.We also observed the hospital days of patients,and followed up patients for six months in order to observe the recurrence rate of COPD.Results The days abou major clinical symptoms which were obviously remitted in treatment group were less than control group(P<0.01).In the meantime,the hospital days and the recurrence rate of COPD were less than control group(P<0.05). Conclusion Montelukast joint atomization inhalation of ambroxol in the treatment of chronic obstructive pulmonary disease have an obvious positive effect.